Related Experiment Video

Updated: Jul 2, 2026

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
08:48

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

Sudden cardiac death in Chagas' heart disease in the contemporary era

Reinaldo B Bestetti1, Augusto Cardinalli-Neto

  • 1Division of Cardiology, Hospital de Base da Faculdade de Medicina de São José do Rio Preto, Brazil. rbestetti@netsite.com.br

International Journal of Cardiology
|August 12, 2008
PubMed

Insights

Sudden cardiac death prevention in Chagas

Area of Science:

  • Cardiology
  • Epidemiology
  • Infectious Diseases

Background:

  • Sudden cardiac death (SCD) is a significant risk in patients with chronic Chagas' heart disease.
  • Life-threatening ventricular tachyarrhythmias are a primary concern for SCD in this population.
  • Current evidence-based guidelines for SCD prophylaxis in Chagas' disease are lacking.

Purpose of the Study:

  • To review the epidemiology, clinical-morphological aspects, and prevention strategies for SCD in chronic Chagas' heart disease.
  • To provide recommendations for primary and secondary prevention of SCD in this patient group.
  • To address the gap in evidence-based guidance for SCD prophylaxis.

Main Methods:

  • Review of existing literature on Chagas' heart disease and SCD.
  • Derivation of prevention strategies from data on non-Chagas' disease patients and expert opinion.
  • Analysis of clinical-morphological aspects and epidemiological data.

Main Results:

  • Non-sustained ventricular tachycardia (VT) in Chagas' disease patients warrants programmed ventricular stimulation.
  • Implantable cardioverter-defibrillators (ICDs) are recommended over amiodarone for inducible VT.
  • Secondary prevention strategies vary based on hemodynamic stability and left ventricular ejection fraction (LVEF).

Conclusions:

  • Primary prevention may involve programmed ventricular stimulation and ICDs for inducible VT.
  • Secondary prevention for hemodynamically unstable patients with malignant ventricular tachyarrhythmias should utilize ICD therapy.
  • Secondary prevention for hemodynamically stable patients involves ICDs, catheter ablation, or drug therapy based on LVEF and electrophysiologic testing.

More Related Videos

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies07:59

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies

Published on: May 31, 2024

Related Concept Videos

American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...